Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthritis Phase II Study Evaluating the Safety and Efficacy of GSK315234A in Patients With Rheumatoid Arthriti ...
A Randomized, Double-blind, Placebo-controlled, Bayesian Adaptive Dose Finding Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Intravenous Infusions GSK315234A in Patients With Active Rheumatoid Arthritis (RA) A Randomized, Double-blind, Placebo-controlled, Bayesian Adaptive Dose Finding Study to Investigate ...
Arthritis, Rheumatoid
Drug: GSK3152314A;Drug: Placebo
GlaxoSmithKline
NULL
Completed
18 Years
75 Years
Both
135
Phase 2
Australia;New Zealand;Russian Federation;Serbia;Ukraine;Former Serbia and Montenegro;United Kingdom